LRMR Larimar Therapeutics, Inc.

Fundamentals / CIK 0001374690 / USD

Larimar Therapeutics, Inc. reported $140.5M in total assets and a net loss of $156.0M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LRMR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$154.9MFY 2016 Revenue: $0FY 2016 Net Income: -$57.88M2016FY 2017 Revenue: $0FY 2017 Net Income: -$52.03M2017FY 2018 Revenue: $0FY 2018 Net Income: -$61.37M2018FY 2019 Revenue: $0FY 2019 Net Income: -$23.13M2019FY 2020 Net Income: -$42.48M2020FY 2021 Net Income: -$50.64M2021FY 2022 Net Income: -$35.35M2022FY 2023 Net Income: -$36.95M2023FY 2024 Net Income: -$80.60M2024FY 2025 Net Income: -$165.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- $0 $0 $0 $0
Research & Development $154.2M $73.28M $27.67M $24.25M $38.40M $31.41M $20.79M $47.93M $40.84M $39.94M
Total Operating Expenses $172.5M $90.89M $41.76M $36.53M $50.47M $42.80M $23.21M $61.12M $53.00M $58.23M
Operating Income -$172.5M -$90.89M -$41.76M -$36.53M -$50.47M -$42.80M -$23.21M -$61.12M -$53.00M -$58.23M
EBITDA -$172.1M -$90.57M -$41.45M -$36.21M -$50.14M -$42.65M -$23.14M -$60.86M -$52.81M -$58.01M
Interest Income -- -- -- -- -- -- $1.99M $1.89M $996K --
Interest Expense -- -- -- -- -- -- $1.77M $1.90M $165K $529K
Income Before Tax -$165.7M -$80.60M -$36.95M -$35.35M -$50.64M -$42.48M -$23.18M -$61.37M -$52.03M -$57.88M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$165.7M -$80.60M -$36.95M -$35.35M -$50.64M -$42.48M -$23.13M -$61.37M -$52.03M -$57.88M
Basic EPS -- -$1.32 -$0.84 -$1.37 -$2.95 -$3.57 -$3.80 -$1.90 -$1.90 -$2.12
Diluted EPS -- -$1.32 -$0.84 -$1.37 -$2.95 -$3.57 -$3.80 -$1.90 -$1.90 -$2.12
Basic Shares Outstanding -- 61.3M 43.9M 25.8M 17.2M 11.9M 6.1M 32.2M 27.4M 27.3M
Diluted Shares Outstanding -- 61.3M 43.9M 25.8M 17.2M 11.9M 6.1M 32.2M 27.4M 27.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $25.93M $28.00M $25.03M $59.37M $44.93M $23.37M $26.55M $26.74M
Total Operating Expenses $32.46M $34.35M $31.12M $64.02M $49.50M $27.79M $31.19M $31.29M
Operating Income -$32.46M -$34.35M -$31.12M -$64.02M -$49.50M -$27.79M -$31.19M -$31.29M
EBITDA -$32.41M -$34.29M -$31.05M -$63.93M -$49.41M -$27.70M -$31.10M -$31.22M
Income Tax Expense -- -- -- -- $0 $0 -- --
Net Income -$31.14M -$32.78M -$29.61M -$62.50M -$47.71M -$26.18M -$29.28M -$28.82M
Basic EPS -- -- -- -- -$0.61 -$0.41 -$0.46 --
Diluted EPS -- -- -- -- -$0.61 -$0.41 -$0.46 --
Basic Shares Outstanding -- -- -- -- 78.3M 64.0M 64.0M --
Diluted Shares Outstanding -- -- -- -- 78.3M 64.0M 64.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $85.41M $33.22M $26.75M $26.82M $70.10M $68.15M $1.01M $49.33M $40.78M $32.35M
Short-Term Investments $51.44M $150.2M $60.04M $91.60M -- $24.49M $43.05M $68.73M $61.27M $96.84M
Cash & Short-Term Investments $136.9M $183.5M $86.80M $118.4M $70.10M $92.64M $70.30M $118.1M $102.1M $129.2M
Total Current Assets $142.0M $195.3M $90.17M $120.7M $72.20M $97.95M $4.75M $121.3M $104.9M $130.9M
Property, Plant & Equipment, Net $622K $881K $684K $831K $1.05M $1.04M $274K $375K $528K $661K
Other Non-Current Assets $523K $596K $659K $638K $669K $419K $90K $57K $57K $61K
Total Non-Current Assets $3.82M $4.92M $5.76M $5.67M $6.46M $6.73M $451K $432K $585K $722K
Total Assets $145.8M $200.2M $95.94M $126.4M $78.67M $104.7M $5.20M $121.8M $105.5M $131.6M
Accounts Payable $5.22M $2.42M $1.28M $1.69M $1.66M $2.63M $3.54M $3.59M $3.02M $2.57M
Total Current Liabilities $64.80M $24.36M $9.51M $10.71M $8.85M $8.99M $5.89M $13.31M $7.29M $9.89M
Long-Term Debt -- -- -- -- -- -- $14.54M $20.00M $20.00M $3.18M
Total Non-Current Liabilities $2.96M $4.06M $4.71M $4.80M $5.41M $6.00M $0 $15.19M $20.00M $0
Total Liabilities $67.76M $28.41M $14.21M $15.50M $14.25M $14.99M $5.89M $28.49M $27.29M $9.89M
Total Debt (incl. Leases) $4.07M $5.12M $5.55M $5.41M $6.00M $6.52M $21.39M $20.00M $20.00M $3.18M
Common Stock $83K $64K $43K $43K $18K $15K $6.0K $37K $27K $27K
Retained Earnings -$434.8M -$269.2M -$188.6M -$151.6M -$116.2M -$65.61M -$23.13M -$350.9M -$289.6M -$237.5M
Accumulated Other Comp. Income $54K $148K $81K -$31K -- $1.0K $35K -$33K -$58K -$80K
Total Stockholders' Equity $78.08M $171.8M $81.72M $110.9M $64.41M $89.69M -$694K $2.91M $78.22M $121.7M
Total Equity $78.08M $171.8M $81.72M $110.9M $64.41M $89.69M -$694K $2.91M $78.22M $121.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $76.99M $92.69M $177.9M $85.41M $90.14M $20.59M $21.13M $33.22M
Short-Term Investments $51.67M $63.58M $22.47M $51.44M $85.30M $117.9M $136.4M $150.2M
Cash & Short-Term Investments $128.7M $156.3M $200.4M $136.9M $175.4M $138.5M $157.5M $183.5M
Total Current Assets $136.2M $160.7M $205.0M $142.0M $183.2M $145.6M $165.5M $195.3M
Property, Plant & Equipment, Net $597K $639K $558K $622K $709K $797K $855K $881K
Other Non-Current Assets $457K $480K $504K $523K $542K $561K $582K $596K
Total Non-Current Assets $4.35M $4.63M $3.53M $3.82M $4.13M $4.43M $4.69M $4.92M
Total Assets $140.5M $165.3M $208.5M $145.8M $187.3M $150.0M $170.2M $200.2M
Accounts Payable $5.11M $7.60M $8.58M $5.22M $11.10M $4.17M $2.27M $2.42M
Total Current Liabilities $35.65M $34.17M $47.76M $64.80M $45.12M $26.65M $22.13M $24.36M
Total Non-Current Liabilities $3.39M $3.75M $2.72M $2.96M $3.20M $3.48M $3.77M $4.06M
Total Liabilities $39.04M $37.92M $50.48M $67.76M $48.31M $30.13M $25.90M $28.41M
Total Debt (incl. Leases) $4.78M $4.96M $3.78M $4.07M $4.35M $4.61M $4.87M $5.12M
Common Stock $104K $103K $103K $83K $86K $64K $64K $64K
Retained Earnings -$528.4M -$497.2M -$464.4M -$434.8M -$372.3M -$324.6M -$298.4M -$269.2M
Accumulated Other Comp. Income -$19K -$12K $6.0K $54K $66K -$9.0K $54K $148K
Total Stockholders' Equity $101.5M $127.4M $158.0M $78.08M $139.0M $119.9M $144.3M $171.8M
Total Equity $101.5M $127.4M $158.0M $78.08M $139.0M $119.9M $144.3M $171.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$165.7M -$80.60M -$36.95M -$35.35M -$50.64M -$42.48M -$23.13M -$61.37M -$52.03M -$57.88M
Depreciation & Amortization $350K $318K $311K $318K $326K $155K $78K $261K $188K $212K
Stock-Based Compensation $7.00M $8.80M $7.62M $6.62M $5.47M $2.16M $129K $9.63M $8.30M $10.11M
Change in Payables $2.79M $1.14M -$403K $26K -$974K -$3.29M $2.63M $432K $448K -$4.62M
Operating Cash Flow -$113.2M -$70.76M -$33.46M -$27.57M -$42.10M -$42.20M -$22.70M -$51.49M -$43.78M -$51.98M
Capital Expenditure -$91K -$515K -$164K -$100K -$333K -$62K -$83K -$108K -$55K -$660K
Free Cash Flow -$113.3M -$71.28M -$33.62M -$27.67M -$42.44M -$42.26M -$22.78M -$51.59M -$43.84M -$52.63M
Purchases of Investments -$83.60M -$227.9M -$101.2M -$133.6M -$8.25M -$24.49M -$82.86M -$117.1M -$114.5M -$136.5M
Investing Cash Flow $100.3M -$85.39M $33.35M -$90.96M $24.17M $17.09M -$83K -$6.87M $35.65M $51.45M
Common Stock Issued $65.09M $161.8M -- $75.26M $19.89M $75.59M -- $64.86M -- --
Financing Cash Flow $65.09M $161.9M $30K $75.26M $19.89M $93.59M $19.39M $66.91M $16.56M -$2.71M
Net Change in Cash $52.19M $5.74M -$76K -$43.27M $1.95M $68.48M -$3.39M $8.55M $8.43M -$3.24M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$31.14M -$32.78M -$29.61M -$62.50M -$47.71M -$26.18M -$29.28M -$28.82M
Depreciation & Amortization $57K $62K $64K $87K $88K $87K $88K $77K
Stock-Based Compensation $2.17M $2.15M $1.98M $1.56M $1.78M $1.83M $1.83M $2.41M
Change in Payables -$2.48M -$557K $2.92M -$5.83M $6.90M $1.87M -$150K $738K
Operating Cash Flow -$31.19M -$44.03M -$44.61M -$38.53M -$28.75M -$19.38M -$26.54M -$21.82M
Capital Expenditure -- -- -- $0 -$23K -$19K -$49K --
Free Cash Flow -- -- -- -$38.53M -$28.78M -$19.40M -$26.59M --
Purchases of Investments -- -- -- $0 -$3.46M -$27.64M -$52.50M -$38.62M
Investing Cash Flow $12.43M -$40.91M $29.00M $34.00M $33.02M $18.84M $14.45M $19.20M
Common Stock Issued $3.05M -$435K $108.1M -- -- -- -- --
Financing Cash Flow $3.05M -$435K $108.1M -- -- -- -- $36K
Net Change in Cash -$15.70M -$85.38M $92.50M -$4.73M $69.55M -$539K -$12.09M -$2.58M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -212.2% -46.9% -45.2% -31.9% -78.6% -47.4% -- -2106.0% -66.5% -47.5%
Return on Assets (ROA) -113.6% -40.3% -38.5% -28.0% -64.4% -40.6% -444.8% -50.4% -49.3% -44.0%
Current Ratio 2.19x 8.02x 9.49x 11.28x 8.16x 10.89x 0.81x 9.12x 14.39x 13.23x
Quick Ratio 2.11x 7.53x 9.13x 11.06x 7.92x 10.30x 11.93x 8.88x 14.00x 13.06x
Debt to Equity 0.05x 0.03x 0.07x 0.05x 0.09x 0.07x -- 6.86x 0.26x 0.03x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -153.8% -135.5% -105.0% -212.2% -94.9% -83.3% -66.0% -46.9%
Return on Assets (ROA) -111.0% -104.4% -79.6% -113.6% -70.5% -66.5% -56.0% -40.3%
Current Ratio 3.82x 4.70x 4.29x 2.19x 4.06x 5.46x 7.48x 8.02x
Quick Ratio 3.61x 4.57x 4.20x 2.11x 3.89x 5.20x 7.12x 7.53x
Debt to Equity 0.05x 0.04x 0.02x 0.05x 0.03x 0.04x 0.03x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001374690) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal